Ropinirole and pramipexole: first dopamine agonists for RLS
Abstract
Ropinirole (Adartrel) and pramipexole (Mirapexin) are two dopamine agonists recently licensed for the treatment of moderate to severe idiopathic restless legs syndrome. In our New products review Steve Chaplin presents the clinical data relating to their effi‐cacy and Dr Ray Chaudhuri comments on their place in treatment. Copyright © 2007 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.64 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network






